Sofosbuvir and Ribavirin is safe and effective therapy in chronic hepatitis C patients with end-stage renal disease on haemodialysis

被引：0
|
作者：
Nayak, Sumanlata [1 ]
Sharma, Manoj [2 ]
Mathur, Rajendra P. [1 ]
Varma, Prem Prakash [1 ]
Gupta, Ekta [3 ]
Choudhary, Ashok [2 ]
Jamwal, Kapil D. [2 ]
Maiwall, Rakhi [2 ]
Kumar, Guresh [2 ]
Bhardwaj, Ankit [2 ]
Sarin, Shiv K. [2 ]
机构：
[1] Inst Liver & Biliary Sci, Nephrol, N Delhi, India
[2] Inst Liver & Biliary Sci, Hepatol, N Delhi, India
[3] Ilbs, Virol, New Delhi, India
来源：
HEPATOLOGY | 2016年 / 64卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
862
引用
收藏
页码：425A / 425A
页数：1
相关论文
共 50 条
  • [1] Sofosbuvir and Velpatasvir combination is safe and effective in treating chronic hepatitis C in end-stage renal disease on maintenance haemodialysis
    Taneja, Sunil
    Duseja, Ajay
    Mehta, Manu
    De, Arka
    Verma, Nipun
    Premkumar, Madhumita
    Dhiman, Radha K.
    Singh, Virendra
    Singh, Mini P.
    Ratho, Radha K.
    Ramachandran, Raja
    Kumar, Vivek
    Kohli, Harbir S.
    LIVER INTERNATIONAL, 2021, 41 (04) : 705 - 709
  • [2] The Fixed Dose Combination of Sofosbuvir and Velpatasvir is Safe and Effective in Patients of Chronic Hepatitis C With End-stage Renal Disease
    Behera, Manas K.
    Majji, Prabir
    Behera, Sanatan
    Pani, Manoj
    Mohapatro, Arupam
    Patra, Umesh C.
    Jena, Susanta K.
    JOURNAL OF CLINICAL AND EXPERIMENTAL HEPATOLOGY, 2024, 14 (04)
  • [3] Sofosbuvir-Based Treatment Is Safe and Effective in Patients With Chronic Hepatitis C Infection and End-Stage Renal Disease
    Alkhouri, Naim
    Guirguis, John
    Anthony, Sumi
    Rivas, John
    Hanouneh, Ibrahim A.
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2015, 110 : S864 - S864
  • [4] Low-Dose Sofosbuvir Is Safe and Effective in Treating Chronic Hepatitis C in Patients with Severe Renal Impairment or End-Stage Renal Disease
    Taneja, Sunil
    Duseja, Ajay
    De, Arka
    Mehta, Manu
    Ramachandran, Raja
    Kumar, Vivek
    Kohli, Harbir Singh
    Gupta, Krishan Lal
    Dhiman, Radha Krishan
    Chawla, Yogesh
    DIGESTIVE DISEASES AND SCIENCES, 2018, 63 (05) : 1334 - 1340
  • [5] Low-Dose Sofosbuvir Is Safe and Effective in Treating Chronic Hepatitis C in Patients with Severe Renal Impairment or End-Stage Renal Disease
    Sunil Taneja
    Ajay Duseja
    Arka De
    Manu Mehta
    Raja Ramachandran
    Vivek Kumar
    Harbir Singh Kohli
    Krishan Lal Gupta
    Radha Krishan Dhiman
    Yogesh Chawla
    Digestive Diseases and Sciences, 2018, 63 : 1334 - 1340
  • [6] Pharmacokinetics of half and full dose of sofosbuvir in chronic hepatitis C patients with end-stage renal disease
    Singhal, Ruchi
    Tiwari, Pramil
    Duseja, Ajay
    Taneja, Sunil
    Ramachandran, Raja
    Patial, Ajay
    Attri, Savita
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2019, 34 : 260 - 260
  • [7] Sofosbuvir and Simeprevir Regimen to Treat Chronic Hepatitis C Infection in Patients With End-Stage Renal Disease
    Guirguis, John
    Anthony, Sumy
    Hanouneh, Ibrahim A.
    Alkhouri, Naim
    GASTROENTEROLOGY, 2015, 148 (04) : S1090 - S1090
  • [8] Low dose sofosbuvir is safe and effective in treating chronic hepatitis C in patients with severe renal impairment or end stage renal disease.
    Duseja, Ajay K.
    Taneja, Sunil
    Mehta, Manu
    De, Arka
    Dhiman, Radha K.
    Chawla, Yogesh K.
    HEPATOLOGY, 2017, 66 : 614A - 615A
  • [9] Percutaneous liver biopsy is safe in chronic hepatitis C patients with end-stage renal disease
    Pawa, Swati
    Ehrinpreis, Murray
    Mutchnick, Milton
    Janisse, James
    Dhar, Ravi
    Siddiqui, Firdous A.
    CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2007, 5 (11) : 1316 - 1320
  • [10] Sofosbuvir-based treatment is safe and effective in patients with chronic hepatitis C infection and end stage renal disease: a case series
    Singh, Tavankit
    Guirguis, John
    Anthony, Sumi
    Rivas, John
    Hanouneh, Ibrahim A.
    Alkhouri, Naim
    LIVER INTERNATIONAL, 2016, 36 (06) : 802 - 806
12345